Ocular Therapeutix, Inc. (OCUL)
NASDAQ: OCUL · Real-Time Price · USD
7.00
-0.25 (-3.45%)
At close: Feb 21, 2025, 4:00 PM
6.98
-0.02 (-0.27%)
After-hours: Feb 21, 2025, 6:44 PM EST

Ocular Therapeutix Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Feb '25 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
1,1014922165341,559190
Upgrade
Market Cap Growth
444.20%127.16%-59.47%-65.74%720.77%15.59%
Upgrade
Enterprise Value
7484641554131,546183
Upgrade
Last Close Price
7.004.462.816.9720.703.95
Upgrade
PS Ratio
15.658.414.2012.2789.5744.93
Upgrade
PB Ratio
3.125.396.126.0720.48-52.32
Upgrade
P/TBV Ratio
3.855.396.126.0720.48-
Upgrade
EV/Sales Ratio
12.187.943.019.5088.8543.26
Upgrade
Debt / Equity Ratio
0.210.921.820.670.77-16.35
Upgrade
Asset Turnover
0.190.290.290.190.100.06
Upgrade
Inventory Turnover
46.6031.0135.9844.4628.5674.15
Upgrade
Quick Ratio
12.596.363.947.049.014.74
Upgrade
Current Ratio
13.016.664.137.269.235.00
Upgrade
Return on Equity (ROE)
-96.89%-127.64%-115.16%-7.99%-429.55%-535.72%
Upgrade
Return on Assets (ROA)
-27.36%-25.66%-27.76%-20.90%-23.06%-70.66%
Upgrade
Return on Capital (ROIC)
-34.47%-37.56%-39.86%-34.65%-41.29%-92.16%
Upgrade
Earnings Yield
-15.84%-16.42%-32.83%-1.23%-9.98%-45.48%
Upgrade
FCF Yield
-10.84%-15.53%-29.26%-12.50%-3.49%-42.03%
Upgrade
Buyback Yield / Dilution
-76.20%-3.57%-0.59%-35.24%-34.19%-18.78%
Upgrade
Total Shareholder Return
-76.20%-3.57%-0.59%-35.24%-34.19%-18.78%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.